デフォルト表紙
市場調査レポート
商品コード
1671839

速溶錠市場:タイプ別、適応症別、剤形別、年齢層別、流通チャネル別、地域別

Fast Melt Tablets Market, By Type, By Indication, By Dosage Form, By Age Group, By Distribution Channel, By Geography


出版日
ページ情報
英文 160 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
速溶錠市場:タイプ別、適応症別、剤形別、年齢層別、流通チャネル別、地域別
出版日: 2025年01月22日
発行: Coherent Market Insights
ページ情報: 英文 160 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の速溶錠市場は、2025年には62億米ドルと推定され、2032年には114億1,000万米ドルに達すると予測され、2025年から2032年までのCAGRは9.1%です。

レポート範囲 レポート詳細
基準年 2024年 2025年の市場規模 62億米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間:2025年~2032年 CAGR: 9.10% 2032年の価値予測 114億1,000万米ドル
図.速溶錠市場シェア(%)、地域別、2025年
Fast Melt Tablets Market-IMG1

速溶錠とは、咀嚼や水を必要とせずに口腔内で瞬時に崩壊・溶解する口腔内崩壊錠を指します。口腔内で速やかに崩壊または溶解するよう最適に設計されているため、嚥下が容易になります。速溶錠は一般に、小児、高齢者、嚥下障害のある患者など、従来の錠剤やカプセルの嚥下が困難な患者を対象としています。速溶錠は、頬腔内で薬剤が溶解・放出されるように設計されているため、嚥下のために水を必要としないです。この技術により、嚥下機能が低下した患者への投与が容易になり、患者のコンプライアンスも向上します。

市場力学:

世界の速溶錠市場は、従来の錠剤やカプセルの嚥下が困難な高齢者人口の増加が牽引しています。主な阻害要因としては、従来の錠剤と比較して速溶錠の製造コストが高いことが挙げられます。しかし、患者のコンプライアンスが向上し、特に小児や老年患者への投与が簡便になるなどの利点があるため、予測期間中に市場成長の有利な機会がもたらされると期待されています。

本調査の主な特徴

本レポートでは、世界の速溶錠市場を詳細に分析し、2024年を基準年とした予測期間(2025~2032年)の市場規模および複合年間成長率(CAGR%)を示します。

また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の速溶錠市場の主要企業をプロファイルしています。

本調査の対象となる主要企業には、Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Amgen Inc., Allergan plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Sun Pharmaceutical Industries Ltd., Strides Pharma Science Limited, and Zydus Cadilaなどが含まれます。

このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品の発売、タイプのアップグレード、市場の拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

この世界の速溶錠市場のレポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。

利害関係者は、世界の速溶錠市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • ドライバ
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界の速溶錠市場、タイプ別、2020年~2032年、(10億米ドル)

  • 抗精神病薬
  • 抗てんかん薬
  • 中枢神経刺激薬
  • 抗不安薬
  • 抗パーキンソン病薬
  • 抗高血圧薬
  • NSAIDs
  • 抗アレルギー薬
  • プロトンポンプ阻害剤
  • その他

第5章 世界の速溶錠市場、適応症別、2020年-2032年、(10億米ドル)

  • 疼痛管理
  • アレルギーおよび呼吸器疾患
  • 神経疾患
  • 胃腸障害
  • 心血管疾患
  • その他

第6章 世界の速溶錠市場、剤形別、2020年~2032年、(10億米ドル)

  • 経口
  • 舌下投与
  • 口腔内投与
  • チュアブル

第7章 世界の速溶錠市場、年齢層別、2020年-2032年、(10億米ドル)

  • 成人
  • 小児
  • 高齢者

第8章 世界の速溶錠市場、流通チャネル別、2020年~2032年、(10億米ドル)

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 世界の速溶錠市場、地域別、2020年-2032年、価値(10億米ドル)

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ
    • 北アフリカ
    • 中央アフリカ

第10章 競合情勢

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Amgen Inc.
  • Allergan plc
  • Aurobindo Pharma Ltd.
  • Hikma Pharmaceuticals plc
  • Sun Pharmaceutical Industries Ltd.
  • Strides Pharma Science Limited
  • Zydus Cadila

第11章 アナリストの推奨事項

  • 運命の輪
  • アナリストの見解
  • 一貫した機会マップ

第12章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI7726

The Global Fast Melt Tablets Market is estimated to be valued at USD 6.20 Bn in 2025 and is expected to reach USD 11.41 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.20 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.10% 2032 Value Projection: USD 11.41 Bn
Figure. Fast Melt Tablets Market Share (%), By Region, 2025
Fast Melt Tablets Market - IMG1

Fast melt tablets refer to orally disintegrating tablets that disintegrate or dissolve instantaneously in the oral cavity without chewing or the need of water. They are optimally designed to rapidly disintegrate or dissolve in the mouth, thereby facilitating swallowing. Fast melt tablets generally target patients who experience difficulties in swallowing conventional tablets and capsules such as pediatric, geriatric patients, and those with dysphagia. Rapidly dissolving tablets are designed to dissolve and release the drugs in buccal cavity eliminating the need of water for swallowing. This technology offers ease of administration to patients with impaired ability to swallow and enhances patient compliance.

Market Dynamics:

The global fast melt tablets market is driven by growing geriatric population who experience difficulty in swallowing conventional tablets and capsules. The key restraining factor includes high cost of manufacturing fast melt tablets as compared to conventional tablets. However, advantages such as enhanced patient compliance and convenience of administration especially for pediatric and geriatric patients is expected to provide lucrative opportunities for market growth over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global fast melt tablets market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fast melt tablets market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Amgen Inc., Allergan plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Sun Pharmaceutical Industries Ltd., Strides Pharma Science Limited, and Zydus Cadila

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fast melt tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fast melt tablets market

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Anti Psychotics
    • Anti Epileptics
    • CNS Stimulants
    • Anxiolytics
    • Anti Parkinsonian Drugs
    • Anti Hypertensive
    • NSAIDs
    • Anti Allergy Drugs
    • Proton Pump Inhibitors
    • Others
  • Indication Insights (Revenue, USD Bn, 2020 - 2032)
    • Pain Management
    • Allergy and Respiratory Disorders
    • Neurological Disorders
    • Gastrointestinal Disorders
    • Cardiovascular Disorders
    • Others
  • Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
    • Oral
    • Sublingual
    • Buccal
    • Chewable
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Adult
    • Pediatrics
    • Geriatrics
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Novartis AG
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Amgen Inc.
    • Allergan plc
    • Aurobindo Pharma Ltd.
    • Hikma Pharmaceuticals plc
    • Sun Pharmaceutical Industries Ltd.
    • Strides Pharma Science Limited
    • Zydus Cadila

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Fast Melt Tablets Market, By Type
    • Global Fast Melt Tablets Market, By Indication
    • Global Fast Melt Tablets Market, By Dosage Form
    • Global Fast Melt Tablets Market, By Age Group
    • Global Fast Melt Tablets Market, By Distribution Channel
    • Global Fast Melt Tablets Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Fast Melt Tablets Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Anti Psychotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Epileptics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • CNS Stimulants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anxiolytics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Parkinsonian Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Hypertensive
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • NSAIDs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Allergy Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Proton Pump Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Fast Melt Tablets Market, By Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Allergy and Respiratory Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiovascular Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Fast Melt Tablets Market, By Dosage Form, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sublingual
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Buccal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chewable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Fast Melt Tablets Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Fast Melt Tablets Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Fast Melt Tablets Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Amgen Inc.
  • Allergan plc
  • Aurobindo Pharma Ltd.
  • Hikma Pharmaceuticals plc
  • Sun Pharmaceutical Industries Ltd.
  • Strides Pharma Science Limited
  • Zydus Cadila

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us